Skip to content

Market Daily

Unveiling the Revolutionary Benefits of Thermography: Comfort, Safety, and Affordability in Detecting Inflammation

In the ever-evolving landscape of healthcare, innovation takes center stage, and the spotlight is now on the remarkable benefits of thermography. In this comprehensive exploration, we dive into the advantages of utilizing thermography for detecting inflammation, offering a compelling narrative that not only informs but motivates readers to consider this cutting-edge technology. Let’s unravel the transformative journey of New York Cryogen and how high-pressure medical cryotherapy, combined with thermography, is changing the game in pain management.

The story begins in November 2021 when Gregory Papageorge embarked on a personal quest for pain relief. Armed with a small medical device, he uncovered the inefficiencies of existing solutions but saw the potential for pain management. This led to the birth of New York Cryogen, a company that has pioneered high-pressure medical cryotherapy, a new technology with the ability to provide profound pain relief and anti-inflammatory effects almost immediately upon application.

Traditional cryotherapy faced limitations due to the lack of tissue penetration. Gregory Papageorge, the creator, cultivator, and inventor of high-pressure medical cryotherapy, introduced an innovative approach. By pressurizing cold cryo gas and applying it to the body, the results were revolutionary. This new modality, endorsed and approved by the American Medical Association (AMA) with exclusive CPT billing codes, offers a groundbreaking option for those suffering from chronic and acute pain.

At the heart of New York Cryogen’s mission is the quest to be an opioid-sparing option for those suffering from chronic and acute pain. The combination of high-pressure cryotherapy and thermography offers a powerful alternative, providing relief without the risks associated with traditional pain management methods. The article aims to enlighten readers about this groundbreaking technology that not only manages pain but also expedites post-surgery healing by up to 80%.

Thermography, a key component in the New York Cryogen approach, plays a pivotal role in detecting inflammation. The comfort, safety, and affordability of thermography make it an attractive option for individuals seeking non-invasive and efficient ways to monitor and manage pain. As part of the revolutionary high-pressure cryotherapy solution, thermography adds a new dimension to the pain management landscape.

New York Cryogen, already recognized as a leader in high-pressure cryotherapy, is making strides with the AC-130 Viper, the first of its kind in the world. Three additional devices are in development, promising to expand the capabilities of this innovative technology. With approvals from Medicare, Medicaid, and integration into seven states on the private insurance side, New York Cryogen is on track to nationalize its reach in 2023, including plans for expansion to Hawaii and Puerto Rico.

As New York Cryogen continues to shape the future of pain management, Gregory Papageorge envisions a landscape where their first portable handheld device is released, enabling the acceptance of healthcare insurance for this combined treatment. The technology is now considered a medical procedure by the AMA, positioning New York Cryogen as a pioneer not only in cryotherapy but also in the broader field of medicine.

Stay updated on their groundbreaking innovations by following New York Cryogen on Instagram (@newyorkcryogen) and Facebook (New York Cryogen). Visit their website at www.nycryogen.comwww.ac130viper.com to learn more about their products and services.

Published by: Nelly Chavez

​​With Growing Demand and Impressive Milestones, Investors Should Pay Attention To This Canadian Stock

PlantX Life Inc. (CSE: VEGA | Frankfurt: WNT1), a Canadian vegan company founded in 2011, is at the forefront of the veganism movement, promoting a healthy and sustainable lifestyle.

The company has quickly grown to become the one-stop shop for everything plant-based by acquiring high-quality businesses, forming strategic partnerships with well-known vegan brands and major e-commerce channels such as thebay.com, amazon.com, Walmart.com, and Walmart.ca as well as delivery platform Instacart. PlantX currently offers over 10,000 plant-based products across North America, including meal and indoor plant delivery services, and is gradually expanding into the United Kingdom, Germany, Austria, and Israel.

The company is experiencing impressive demand for its product and services resulting in strong revenue growth.

Figure 1: PlantX 2022 Monthly Progress

Source: PlantX Press Releases

March was the best month for the company so far with revenue increasing 168% year-over-year as the company expanded into new markets such as Austria and the Republic of Ireland. The company also collaborated with BESTIES Vegan Paradise (“BESTIES”), the only vegan marketplace in the country selling products exclusively from 100% vegan brands, to redesign and rebrand PlnatX’s brick-and-mortar stores in Venice and Hillcrest, California, as BESTIES. This collaboration resulted in an increase of 30% in sales revenue in the first month since PlantX’s Venice location was rebranded to reflect the BESTIES model. In March, the company also announced same-day grocery delivery across Ottawa and Toronto to broaden its on-demand delivery options.

In July, PlantX generated monthly gross revenue of $1.2 million, a 35% increase over July 2021. Little West, a brand of cold-pressed juice that PlantX acquired in 2021, contributed significantly to this growth. Little West offers a diverse range of beverages and products made from locally sourced, high-quality, and fresh ingredients, which are selling well as people return to offices and coffee shops. On August 3, the company announced the expansion of Little West to Canada. Little West has launched a Canadian version of its e-commerce website and plans to expand wholesale distribution throughout the country.

PlantX is expected to be one of the long-term winners as veganism brings significant changes to the food industry. Capital Y Management, a New York-based hedge fund, published an independent research report on PlantX in July, referring to the company as “a market leader with a revolutionary business in a growing industry with long-term tailwinds.” Capital Y Management has set PlantX a 12-month price target of C$0.67 per common share, equating to a C$68 million enterprise value for the company. According to the report, PlantX’s partnerships with Amazon and Walmart are likely to increase the company’s sales by 12%.

PlantX seems poised for sustainable growth as it continues to invest heavily in improving the quality of its existing services and programs in order to raise brand awareness and expand its customer base. PlantX announced the U.S. expansion of its XMeals online platform on June 23 by launching its new website, xmeals.com. XMeals provides a subscription service as well as one-time purchases from PlantX’s weekly à la carte menu options. Customers in the United States will now be able to access XMeals’ plant-based menu items, chef-curated meals, and 3- and 5-day meal plans selected by a licensed dietitian and member of the Medical Advisory Board.

Additionally, PlantX has been granted permission to sell and distribute alcoholic beverages at its retail locations in Chicago, Illinois, and Venice Beach, California. With the alcohol license, the company will be able to deliver alcoholic beverages across the United States for orders placed on its U.S. e-commerce platform, as well as offer same-day delivery through partnerships with UberEats and Instacart. The authorization grants PlantX access to the $284.10 billion alcoholic beverages market, and PlantX’s goal of providing high-quality, sustainable, and ethical alcoholic beverages will provide the company the competitive edge it needs to succeed.

PlantX has accomplished significant milestones this year and continues to expand its partnerships and product offerings. The company’s strong brand portfolio and online channels continue to drive positive revenue growth. In addition, PlantX is eliminating entry barriers to promote environmentally friendly and animal cruelty-free living by supporting new and established plant-based brands through the “Vegan Popup by XMarket” initiative. These initiatives, including a customer awareness program, partnerships, and an expansion plan, have all produced excellent results and will continue to do so in the future.

Navigating the Current Market: What Spikes in Inflation Mean for your Stock Portfolio

Inflation in the US has become one of the most popular topics in headlines during the past few months, with many articles focused on why it is spiking and what can be done to bring it under control. The big question for investors, however, has been what to expect from the market as spikes in inflation continue to affect the economy.

“The general impact of inflation on the market is insidious,” explains Josh Answers. “It’s gradual and subtle at the same time, which is why gauging its real impact on the market can feel elusive.”

Josh is a financial streaming pioneer and 15-year stock market veteran who hosts the YouTube channel The Trading Fraternity as well as The Stock Market Live, where he streams live content seven hours a day covering the stock market and finance markets. 

“The cold fact of the matter is that nobody really knows how the market is going to respond,” Josh says. “This is why a lot of people — myself included — flip back through history books to see what happened the last time anything like this occurred. Looking back at the track record of the 1970s, you find a lot of features that are similar to today. I would say the 70s provide us with a perspective to help navigate through this inflationary period.”

As Josh explains, inflation in the US in the late 1970s rose from 2.7 percent to 12.3 percent in less than 24 months. It then declined slightly for a year before jumping back up to 14.7 percent. During that cycle, which took almost a full decade to complete, inflation rates experienced numerous spikes and drops.

“Inflation doesn’t just surge up overnight,” Josh explains. “The spikes that we see are essentially the process through which inflation builds up or sheds down. Spikes in inflation in the 1970s pretty much came in two year blocks, and that seems to be the same trajectory we are on today.”

In April of 2021, The White House announced that inflation, which it identified as a possible effect of the COVID-19 pandemic, was a risk that it was “monitoring closely.” As inflation rose throughout the summer of 2021, the US Federal Reserve labeled it transitory, believing that the factors causing the increase would correct themselves. By January 2022, however, inflation in the US had hit a 40-year high and was continuing to climb. In recent months, experts have proclaimed that protracted, not transitory, is the correct terminology for describing this period of inflation.

“It’s hard to anticipate anything in this environment, but it is certain that volatility will plague us until we gain more certainty on where the economy and policy are going,” Josh says. “With that in mind, you shouldn’t be afraid of volatility, but you should be prepared.”

One approach that experts advise in the current market is maintaining a balanced portfolio and keeping a keen eye on cash balances. Although buying is not something that investors should fear during times of inflation, they should avoid positioning themselves too heavily in any one sector.

“At the later end of the inflationary cycles — the final spike — stocks tend to outperform, so there is nothing wrong with holding on to some growth stocks,” Josh explains. “Still, in an inflationary environment, dividend stocks are some of the best hedges as they provide stable income that usually increases on a yearly basis. The dividend yields can compound and help pad the stats if the volatility lasts longer than expected.”

Another lesson to learn from the inflation in the 1970s is that inflationary spikes do not last forever. Navigating the current market may be like sailing through a storm, but the storm will eventually pass.

“Any investor can outlast any storm with enough time and money,” Josh says. “There may be some economic pain with the market paying the price, but history tells us they always climb back. I preach the long-term portfolio and waiting it out. In some cases, investors are better off smashing their computer after buying a stock and not looking at its performance for years. If you are on the younger side, and have time on your side, a long-term approach and focus is the way to go.”